Top Health-care stocks:
Health-care shares were generally unchanged in pre-market trade Monday.
In health-care stocks news, Shares of Neothetics Inc. ( NEOT ) gained pre-market Monday after the company said it is commencing two pivotal Phase 3 trials to determine the efficacy, safety and tolerability of LIPO-202 for reducing central abdominal bulging. The specialty pharmaceutical firm said the two trials will be conducted in approximately 80 sites across the U.S and enroll a total of 1,600 patients.
Shares in the company were trading 1.2% higher at $8.25 during pre-market trading . Over the past 52 weeks, the company has traded between $6.11 and $14.10.
AEterna Zentaris ( AEZS ) said Monday it plans to conduct a phase 3 clinical study to demonstrate the efficacy of Macrilen (macimorelin), an orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency ( AGHD ). The study will also evaluate the effects of Macrilen on myocardial repolarization.
Shares in the company were trading 4.8% higher at $0.54 during pre-market trading. Over the past 52 weeks, the company has traded between $0.48 and $1.54.
And Recro Pharma ( REPH ), a development stage biopharmaceutical company, said Monday it has completed its previously announced acquisition of assets from Ireland-based Alkermes plc ( ALKS ) and its affiliates.
Shares in the company were unchanged at $11.17 during pre-market trading. Over the past 52 weeks, the company has traded between $2.36 and $11.70.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.